Paul Treacy, SVP, Technical Operations at Jazz Pharmaceuticals plc (JAZZ), sold 8,742 shares at $137.40 ($1.2M) on 2019-08-12, disclosed to the SEC on 2019-08-14.
Seasonal sale ($1.2M) by SVP, Technical Operations — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $137.40 | 4,371 | $601K | 50.0% |
| 2 | $137.40 | 4,371 | $601K | 50.0% |
| Total | $137.40 avg | 8,742 | $1.2M | 100% |
| Filing → |
| JAZZ | SELL | 2018-08-13 | $462K | — | Filing → |
| JAZZ | SELL | 2018-03-07 | $168K | — | Filing → |
| JAZZ | SELL | 2018-03-05 | $196K | — | Filing → |